Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects

NCT00302367 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00302367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00302367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2004
Completion date
April 30, 2004
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers